Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (412)

  • Ramos-Ruperez, E; Escudero-Vilaplana, V; Ruiz-Briones, P; Collado-Borrell, R; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Garcia-Gonzalez, X; Ibanez-Garcia, S; Perez-Ramirez, S; Zatarain-Nicolas, E; Herranz, A; Sanjurjo, M.

    Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

    Frontiers in Oncology. 2023; 13: Nº de citas: 2 [doi:10.3389/fonc.2023.1220305]

  • Yuste, I; Luciano, FC; Anaya, BJ; Sanz-Ruiz, P; Ribed-Sanchez, A; Gonzalez-Burgos, E; Serrano, DR.

    Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections

    Antibiotics-Basel. 2023; 12(8): [doi:10.3390/antibiotics12081229]

  • Bermejo-Gomez, A; Aguilera-Alonso, D; Rincon-Lopez, EM; Catalan-Alonso, P; Bardon-Cancho, EJ; Garcia-Morin, M; Manrique-Rodriguez, S; Navarro-Gomez, ML.

    Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

    PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2023; 42(8): 290-292 [doi:10.1097/INF.0000000000003938]

  • Zapata-Cobo P; Salvador-Martín S; Velasco M; Palomino LM; Clemente S; Segarra O; Moreno-Álvarez A; Fernández-Lorenzo A; Pérez-Moneo B; Montraveta M; Sánchez C; Tolín M; Loverdos I; Fobelo MJ; Navas-López VM; Magallares L; García-Romero R; Sánchez-Hernández JG; Rodríguez A; Bossacoma F; Balboa MJ; Salcedo E; Sanjurjo-Sáez M; López-Fernández LA.

    Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.

    PHARMACOLOGICAL RESEARCH. 2023; 194: 106859-106859 Nº de citas: 5 [doi:10.1016/j.phrs.2023.106859]

  • Beatriz GC; María José O; Inés JL; Yolanda HG; Concha ÁD; Javier TS; Cecilia M FL.

    Medication errors in children visiting pediatric emergency departments.

    FARMACIA HOSPITALARIA. 2023; 47(4): [doi:10.1016/j.farma.2023.06.001]

  • Borras-Blasco J; Herráiz ER; Sánchez PL; Romero-Jimenez R; Navarro-Ruiz A; Sola NR.

    Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis.

    FARMACIA HOSPITALARIA. 2023; 47(4): 148-154 [doi:10.1016/j.farma.2023.03.007]

  • Beatriz, GC; Jose, OM; Ines, JL; Yolanda, HG; Concha, AD; Javier, TS; Cecilia, MFL.

    Medication errors in children visiting pediatric emergency departments

    FARMACIA HOSPITALARIA. 2023; 47(4): 141-147 Nº de citas: 8 [doi:10.1016/j.farma.2023.03.006]

  • Borras-Blasco, J; Herraiz, ER; Sanchez, PL; Romero-Jimenez, R; Navarro-Ruiz, A; Sola, NR.

    Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis

    FARMACIA HOSPITALARIA. 2023; 47(4): 148-154 [doi:10.1016/j.farma.2023.05.007]

  • Gonzalez, CGR; de Vega, EC; Martinez, SD; Minero, MV; Urbon, JMG; Manzorro, AG; Martinez, EFD; Sacristan, SC; Santiago, EB; Alonso, AH; de Paredes, PMG; Saez, MS.

    A critical view on the current use of daptomycin in Spain: The daptomise study

    Journal of Infection and Public Health. 2023; 16(7): 1115-1122 Nº de citas: 1 [doi:10.1016/j.jiph.2023.05.008]

  • Escudero-Vilaplana, V; Collado-Borrell, R; Martinez-Sagrera, PG; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Hoyo-Munoz, A; Gilarranz, YJ; Marzal-Alfaro, B; Herranz, A; Martin, M; Sanjurjo, M.

    Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 2855-2882 Nº de citas: 4 [doi:10.1007/s00432-022-04172-1]

  • Palomino-Cabrera, R; Tejerina, F; Molero-Salinas, A; Ferris, M; Veintimilla, C; Catalan, P; Macias, GR; Alonso, R; Munoz, P; de Viedma, DG; Perez-Lago, L.

    Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023; 67(7): Nº de citas: 6 [doi:10.1128/aac.00266-23]

  • Martin, MT; Boquet, EM; Aznares, HN; Cortes, MDR; Gonzalez, CR; de las Hazas, JISL; Morillo-Verdugo, R.

    2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus

    FARMACIA HOSPITALARIA. 2023; 47(3): 113-120 Nº de citas: 2 [doi:10.1016/j.farma.2023.01.007]

  • Conde, MTM; Boquet, EM; Aznares, HN; Cortes, MDR; Gonzalez, CR; de las Hazas, JISL; Morillo-Verdugo, R.

    [Translated article] 2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus

    FARMACIA HOSPITALARIA. 2023; 47(3): 113-120 [doi:10.1016/j.farma.2023.04.008]

  • Ruiz-Briones, P; Escudero-Vilaplana, V; Collado-Borrell, R; Vicente-Valor, J; Alvarez, R; Villanueva-Bueno, C; Narrillos-Moraza, A; Herranz, A; Sanjurjo, M.

    Possible heart failure caused by osimertinib in a lung cancer patient

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023; 29(4): 1015-1020 Nº de citas: 4 [doi:10.1177/10781552221143787]

  • Arhip, L; Camblor, M; Breton, I; Motilla, M; Serrano-Moreno, C; Romero, RM; Lobato, E; Frias, L; Velasco, C; Carrascal, ML; Cuerda, C.

    Implementation of a parenteral nutrition home care programme in a tertiary hospital

    NUTRICION HOSPITALARIA. 2023; 40(3): 476-484 [doi:10.20960/nh.04494]

  • Garcia-Martin, E; Romero-Jimenez, RM; Baniandres-Rodriguez, O; Escudero-Vilaplana, V; Benedi-Gonzalez, J; Luna, PMD; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; 31(5): 409-415 Nº de citas: 2 [doi:10.1136/ejhpharm-2022-003594]

  • Garcia-Gonzalez, X; Cubo, E; Simon-Vicente, L; Mariscal, N; Alcaraz, R; Aguado, L; Rivadeneyra-Posadas, J; Sanz-Solas, A; Saiz-Rodriguez, M.

    Thermodynamical Analysis of the Formation of a-Si Ring Structures on Silicon Surface

    Journal Of Personalized Medicine. 2023; 13(3): Nº de citas: 7 [doi:10.3390/jpm13030385]

  • Villanueva-Bueno, C; Montecatine-Alonso, E; Jimenez-Parrilla, F; Gonzalez-Lopez, M; Manrique-Rodriguez, S; Moreno-Ramos, F; Canete-Ramirez, C; Dolz, E; Garcia-Robles, A; Caro-Teller, JM; Moral-Pumarega, MT; Bergon-Sendin, E; Calvo, MTGT; Gallego-Fernandez, C; del Vayo-Benito, CA; Mejias-Trueba, M; Gil-Navarro, MV.

    Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

    Antibiotics-Basel. 2023; 12(3): Nº de citas: 2 [doi:10.3390/antibiotics12030602]